let's do some historylundgren wrote: ↑Tue Nov 24, 2020 11:18 amWell so i will ask a simple question (go maybe two questions)Phill wrote: ↑Mon Nov 23, 2020 1:35 am here the full text of 5 scenario you mentioned in your link
https://www.cghjournal.org/article/S154 ... 8/fulltext
apart from the fact that these men do not seem so damaged, but then they are 5 isolated cases.
ok we all know 17 alpha achylated steroids do liver damage, but I mean ... 5 sporadic cases of 5 people who who knows what they had.
in addition I quote verbatim:
"Occasional impurities in the mass production of methasteron may have lead to these isolated cases of cholestasis and hepatotoxicity."
Impurities in production...lead isolated cases.
Why was this molecule never marketed?
Why was Anabolic Xtreme ordered to stop the production and sale of Superdrol (ask by FDA)
And if for your the ratio are and if you are relying on the anabolic / androgenic ratio to determine whether it is good or bad for a women, would you also recommend Anadrol ?
It's amazing because Anabolic Xtreme has never recommended Superdrol to women
And from my personal experience i maintain the Superdrol push the liver more than :
With 50mg Anadrol / day the liver is not as affected as with 10mg Superdrol after 3 weeks (from my experience feeling & blood work)
If i compare 20mg of Superdrol vs 20mg Stanozolol, again no doubt Superdrol are more toxic.
And i'm sure at 100% 20mg Superdrol are more toxic vs 20mg Anavar
Methyldrostanolone was first described in 1956 in connection with research conducted by the Syntex Corporation to discover a compound with anti-tumor properties. In an article published in 1959, it is initially mentioned, its method of synthesis and its proven anti-tumor properties being discussed in detail, describing it as a "potent orally active anabolic agent exhibiting only weak androgenic activity." The results of the tests subsequent to the determination of the anabolic / androgenic activity of Methyldrostanolone were published in Vida's Androgens and Anabolic Agents, a dated but still valid reference, in which it was observed that the molecule possesses the oral bioavailability of Metyltestosterone despite being 400% more anabolic and 20% androgenic, yielding a Q-ratio (also known as the anabolic / androgenic ratio) of 20, which is considered very high.
Compared to injectable Testosterone the ratio of Methyldrostanolone becomes about 20/600.
Methyldrostanolone was never marketed as a drug. As is well known, its non-17α-alkylated counterpart, Drostanolone, was marketed by the Syntex Corporation under the brand name Masteron.
Methyldrostanolone re-emerged in 2005 in the "designer steroid" market. It was brought to the market by steroid designers as an ingredient in a "food supplement" called Superdrol. Its commercial introduction may have represented an attempt to circumvent the U.S. Anabolic Steroids Control Act of 1990 (along with its 2004 revision), since the law is, in part, related to specific drugs; Methyldrostanolone, as has happened for many other steroid designers, was not declared in the Anabolic Substances Control Act because it was not commercially available at the time of writing, as it was not when the next revision was signed. As a result, Superdrol was sold as an over-the-counter dietary supplement.
In late 2005, Superdrol's anabolic steroid status, in addition to that of four other steroid designers, was brought to the attention of the public by an article published in the Washington Post. Don Catlin of the UCLA Olympic Laboratory, who conducted the studies, noted the similarity of Superdrol to Drostanolone. A warning from the FDA was issued shortly thereafter to the public as well as to the distributor, Designer Supplements LLC, for marketing this compound. Methyldrostanolone was later added to the World Anti-Doping Agency (WADA) list of banned substances in sport. Despite all of this, Methyldrostanolone has re-emerged in the supplement industry on several occasions since its ban by WADA.
Superdrol may prove to be one of the safest AAS for women trying to avoid androgenic side effects.
it is less androgenic than anavar (widely used) and has much higher anabolic capabilities.
5 mg of SD provides a weaker androgenic effect than 10 mg of Oxandrolone and therefore a reduced likelihood of experiencing masculinizing effects.
SD is arguably one of the most powerful muscle builders. Very few steroids sold today, whether on the black market, or by prescription or OTC, exceed this drug's ability to add muscle tissue per effective dose. On the contrary, Oxandrolone is known as one of the less brilliant steroids when it comes to muscle growth. In terms of real-world results, SD excels over almost all other steroids available.
In medicine, androl is widely used on women and children.
Sure, it is known to be hepatotoxic and androgenic, but the alternatives are worse, so yes, anadrol is also a great steroid for women.
a word about hepatotoxicity.
I don't want to sell superdrol as safe and/or less hepatotoxic than other oral steroids, but just refer to a fact that has grown this popularity as a liver destroyer.
as mentioned, this product was sold as a dietary supplement and never as a drug. no guidelines were given on dosages and maximum times of intake, consequently the users of those years used it at high dosages and for a long time.
Now, you can understand that using a hepatotoxic product for the whole year round (because it's just a food supplement and nothing more), has a considerable impact on the liver compared to only 6 weeks on another steroid.
